In an era where healthcare consumer roles are evolving from recipients to proactive participants, a growing number of stakeholders have employed a patient-centric approach in shaping healthcare access and delivery.
Empowered by an unprecedented level of access to information, patients are increasingly influencing decisions that affect their care, including therapeutic use.
This paradigm shift of the consumer’s role means manufacturers that integrate a patient perspective throughout the drug life cycle can better ensure that evidence generation focuses on endpoints important to patients and that market access strategies are tailored to patient needs, preferences and priorities.
Check out the rest of the feature here
